Maria Cincotta

Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer

Stephen Chan, M. E. Scheulen, S. Johnston et al. · Journal of Clinical Oncology · 2005 · 468 citations · Full text

Medicine, Oncology, Pharmacology +16

Effects of Genistein and Hormone-Replacement Therapy on Bone Loss in Early Postmenopausal Women: A Randomized Double-Blind Placebo-Controlled Study

Nunziata Morabito, Alessandra Crisafulli, Caterina Vergara et al. · Journal of Bone and Mineral Research · 2002 · 432 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Antonio C. Wolff, Ann Lazar, Igor Bondarenko et al. · Journal of Clinical Oncology · 2012 · 272 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Osteoprotegerin and RANKL in the Pathogenesis of Thalassemia-Induced Osteoporosis: New Pieces of the Puzzle

Nunziata Morabito, Agostino Gaudio, Antonino Lasco et al. · Journal of Bone and Mineral Research · 2004 · 126 citations

Medicine, Endocrinology, Bone Metabolism +16

Drug-Related Pneumonitis in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus

Gary R. Hudes, Janice P. Dutcher, Theodore F. Logan et al. · Journal of Clinical Oncology · 2011 · 108 citations · Full text

Medicine, Oncology, Pharmacology +13